The effectiveness and safety of octocog alfa in patients with hemophilia A: up to 7-year follow-up of the real-world AHEAD international study.
Margareth Castro OzeloCedric HermansManuel D CarcaoPhilippe GautierJoan GuRandy GuerraLeilei TangKate KhairPublished in: Therapeutic advances in hematology (2024)
ClinicalTrials.gov: NCT02078427.
Keyphrases